SCHEMBL31394

SCHEMBL31394

O=C(O)c1cc2ccccc2[nH]c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.59
DAO P14920 2/20 0.59
MAPT P10636 1/20 0.59
HPGD P15428 1/20 0.59
SRD5A2 P31213 1/20 0.59
HSD17B10 Q99714 1/20 0.59
DDO Q99489 1/20 0.59
ALDH1A1 P00352 1/20 0.58
POLB P06746 1/20 0.58
GAA P10253 1/20 0.58
BRD4 O60885 1/20 0.55
SMYD3 Q9H7B4 2/20 0.52
FLT3 P36888 1/20 0.52
CHEK1 O14757 1/20 0.51
KDR P35968 1/20 0.51
PADI4 Q9UM07 2/20 0.51
MAPK1 P28482 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
PARP1 P09874 1/20 0.50
GRIN2D O15399 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364659 1.00 KDM4E (0.59) KDM4EDAOMAPTHPGDSRD5A2
Hydrochloric Acid SCHEMBL5027809 0.98 KDM4E (0.58) KDM4EDAOMAPTHPGDSRD5A2
Fluoride SCHEMBL29664116 0.98 KDM4E (0.58) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL27578750 0.89 KDM4E (0.49) KDM4EDAOMAPTHPGDSRD5A2
Glycerin SCHEMBL27539640 0.88 KDM4E (0.48) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL1367711 0.87 DAO (0.61) KDM4EDAOMAPTHPGDSRD5A2
Quinoline SCHEMBL11495860 0.85 PADI4 (0.50) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL16627746 0.84 DAO (0.58) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL29390425 0.84 DAO (0.58) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL29505966 0.84 DAO (0.58) KDM4EDAOMAPTHPGDSRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113185505-B Quinolone oxazolidinone compound and preparation method and application thereof 中国农业大学 2022-09-27 CN claimed
US-11332444-B2 Method for the hydrolysis of quinolonecarboxylic esters BAYER ANIMAL HEALTH GMBH (DE) 2022-05-17 US claimed
CN-113185505-A Quinolone oxazolidinone compound and preparation method and application thereof 中国农业大学 2021-07-30 CN claimed
US-20210078950-A1 METHOD FOR THE HYDROLYSIS OF QUINOLONECARBOXYLIC ESTERS ELANCO ANIMAL HEALTH GMBH (DE) 2021-03-18 US claimed
EP-3784656-A1 PROCESS FOR THE HYDROLYSIS OF QUINOLONE CARBOXYLIC ESTERS Bayer Animal Health GmbH (DE) 2021-03-03 EP claimed
CN-106674254-B Quinolone carboxylic acid compounds and intermediates, preparation method and application thereof 广东省中医院 2019-03-15 CN claimed
CN-109251211-A A kind of quinolonecarboxylic acid compound and its intermediate, preparation method and application 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 2019-01-22 CN claimed
US-9994444-B2 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease ALLACCEM, INC. (US) 2018-06-12 US claimed
CN-106674254-A Quinolone carboxylic acid compounds and intermediates, preparation method and application thereof 广东省中医院 2017-05-17 CN claimed
CN-106572982-A Antimicrobial compositions with effervescent agents 梅琳塔治疗公司 2017-04-19 CN claimed
EP-0176846-B1 3-AMINO-2-BENZOYL-ACRYLIC-ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION BAYER AG (DE) 1989-08-16 EP claimed
EP-0311948-A2 Quinolonecarboxylic acid compounds and pharmaceutical use thereof Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1989-04-19 EP claimed
US-4680401-A Preparation of halogenated quinolonecarboxylic acids BAYER AKTIENGESELLSCHAFT (DE) 1987-07-14 US claimed
CN-86104256-A 1, the preparation method of 8-bridging 4-quinolone-3-carboxylic-acid 1987-03-18 CN claimed
EP-0117473-B1 QUINOLONE CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND ANTIBACTERIAL COMPOSITIONS CONTAINING THEM BAYER AG (DE) 1987-01-28 EP claimed
EP-0117474-B1 QUINOLONE CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND ANTIBACTERIAL COMPOSITIONS CONTAINING THEM BAYER AG (DE) 1986-10-29 EP claimed
EP-0118854-B1 BACTERICIDAL AGENT CONTAINING QUINOLONE-CARBOXYLIC ACIDS BAYER AG (DE) 1986-07-23 EP claimed
US-4559341-A Quinolonecarboxylic acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1985-12-17 US claimed
US-4559342-A Quinolone acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1985-12-17 US claimed
EP-0012925-B1 QUINOLON-CARBOXYLIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1982-11-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078950-A1 METHOD FOR THE HYDROLYSIS OF QUINOLONECARBOXYLIC ESTERS NQO2, PGD, ALAD KDM4E 2839/4885DAO 176/4885MAPT 4256/4885
US-11332444-B2 Method for the hydrolysis of quinolonecarboxylic esters NQO2, PGD, ALAD KDM4E 2839/4885DAO 176/4885MAPT 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.